Table of Content




1. Executive Summary


2. Global Induced Pluripotent Stem Cell Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Induced Pluripotent Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Induced Pluripotent Stem Cell Market by Workflow
3.3.1: Reprogramming
3.3.2: Cell Culture
3.3.3: Cell Characterization / Analysis
3.3.4: Engineering
3.3.5: Others

3.4: Global Induced Pluripotent Stem Cell Market by Application
3.4.1: Drug Development & Discovery
3.4.2: Regenerative Medicine
3.4.3: Toxicology Studies
3.4.4: Others


3.5: Global Induced Pluripotent Stem Cell Market by End Use
3.5.1: Research & Academic Institutes
3.5.2: Biotechnology & Pharmaceutical Companies
3.5.3: Hospitals & Clinics




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Induced Pluripotent Stem Cell Market by Region
4.2: North American Induced Pluripotent Stem Cell Market
4.2.1: North American Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.2.2: North American Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics

4.3: European Induced Pluripotent Stem Cell Market

4.3.1: European Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.3.2: European Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics

4.4: APAC Induced Pluripotent Stem Cell Market

4.4.1: APAC Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.4.2: APAC Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics

4.5: ROW Induced Pluripotent Stem Cell Market

4.5.1: ROW Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.5.2: ROW Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Workflow
6.1.2: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Application
6.1.3: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by End Use

6.1.4: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Region

6.2: Emerging Trends in the Global Induced Pluripotent Stem Cell Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Induced Pluripotent Stem Cell Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Induced Pluripotent Stem Cell Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Lonza
7.2: Axol Bioscience
7.3: Evotec
7.4: Hitachi
7.5: REPROCELL
7.6: Merck
7.7: REPROCELLS
7.8: Fate Therapeutics
7.9: Thermo Fisher Scientific
7.10: StemCellsFactory III